LifeVantage to Participate in the Sidoti Small Cap Conference
Rhea-AI Summary
LifeVantage (Nasdaq: LFVN) will participate in the Sidoti Small Cap Conference March 18-19, 2026. CEO Steve Fife and CFO Carl Aure will meet virtually with investors and present on March 19, 2026 at ~4:00 p.m. ET.
A live webcast of the presentation will be available on the company’s Investor Relations News & Events page.
Positive
- None.
Negative
- None.
News Market Reaction – LFVN
On the day this news was published, LFVN gained 0.77%, reflecting a mild positive market reaction. Argus tracked a trough of -5.3% from its starting point during tracking. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $483K to the company's valuation, bringing the market cap to $63M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers showed mixed moves: HAIN up 7.19%, BYND up 2.31%, while FTLF and BRCC declined. Momentum scanner flagged only ATPC moving down, suggesting this headline is more company-specific than part of a broad sector trend.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 04 | Dividend declaration | Positive | -16.8% | Announced $0.045 quarterly cash dividend as return of capital. |
| Feb 04 | CEO transition | Negative | -16.8% | Planned April 2026 retirement of CEO Steve Fife and succession process. |
| Feb 04 | Earnings results | Negative | -16.8% | Q2 FY26 revenue and earnings declined; inventory charge pressured margins. |
| Jan 21 | Earnings date set | Neutral | +4.7% | Scheduled Q2 FY26 release and conference call details for Feb 4, 2026. |
| Jan 12 | Product/strategy update | Positive | -8.7% | Global Kickoff event with app launch and Healthy Edge system data. |
Recent news often saw sharp moves: weak Q2 results and leadership changes coincided with a -16.76% drop, while more promotional or dividend-related updates sometimes faced negative reactions.
Over the last few months, LifeVantage reported weaker Q2 fiscal 2026 results with revenue at $48.9M and net income at $0.3M, alongside guidance and a new $60M repurchase program. The same day, the company announced CEO Steve Fife’s planned April 2026 retirement and declared a $0.045 quarterly dividend, with shares falling 16.76%. Earlier, a Global Kickoff event highlighting LoveBiome integration and new digital tools coincided with an 8.69% decline, while the Q2 earnings date announcement saw a modest 4.74% gain. Today’s conference participation fits into this pattern of frequent investor-facing communications.
Regulatory & Risk Context
An effective S-3 shelf dated Mar 10, 2026 registers up to $75.0 million of securities, allowing LifeVantage to offer common or preferred stock, debt, warrants, or units from time to time via various distribution methods. No usage has been recorded yet in the provided data.
Market Pulse Summary
This announcement centers on LifeVantage’s participation in the Sidoti Small Cap Conference, offering another investor touchpoint after a period that included weaker Q2 results, a CEO retirement plan, and a new S-3 shelf for up to $75.0 million of securities. With the stock at $5.19, below its $9.15 200-day MA and well under the $17.64 52-week high, investors may watch for how management’s conference messaging aligns with recent financial trends and capital-raising flexibility.
AI-generated analysis. Not financial advice.
SALT LAKE CITY, March 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Sidoti Small Cap Conference, to be held March 18-19, 2026.
Mr. Fife and Mr. Aure will meet virtually with investors and present at approximately 4:00 p.m. Eastern Time on Thursday, March 19, 2026. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and the comprehensive gut activator, P84, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When will LifeVantage (LFVN) present at the Sidoti Small Cap Conference?
How can investors watch the LifeVantage (LFVN) Sidoti presentation live?
Who from LifeVantage (LFVN) will attend the Sidoti Small Cap Conference?
What date(s) is the Sidoti Small Cap Conference where LFVN will participate?
Where is the LifeVantage (LFVN) Sidoti presentation archived after the live event?
